Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Looking for ways to make quick cash for free? Here are some straightforward tips to help you earn extra money effortlessly.
21,880 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Mortgage originations in 2026 are shifting from chasing lower rates to serving life events. Relocation, growing famil...
As workers reassess early retirement, a dividend-heavy portfolio could substitute lost full-time income. This piece b...
A fresh Apollo analysis flags a widening profit gap for AI initiatives outside core tech, threatening AI-heavy ETFs a...
From a tiny boat-insurer niche to a public company, Hagerty’s story is a case study in branding, community, and strat...
A fresh Federal Reserve briefing shows a modest emergency cushion among households, but retirement readiness remains ...
Berkshire Hathaway slashed its Amazon holding by 77% in the fourth quarter, leaving a lean position and sparking rene...
Atlassian Corp. PLC posted stronger-than-expected Q1 results, but its stock has still tumbled. With 25 analysts stick...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
Fidelity's Dividend ETF for Rising Rates has surged 23% over the last year, but the fund’s tech-heavy, rate-sensitive...
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
Two durable, under-the-radar businesses outpaced the market for 10 years, underscoring the value of steady margins an...